Logotype for Catheter Precision Inc

Catheter Precision (VTAK) Proxy Filing summary

Event summary combining transcript, slides, and related documents.

Logotype for Catheter Precision Inc

Proxy Filing summary

13 Mar, 2026

Executive summary

  • Special Meeting scheduled for April 15, 2026, to vote on six key proposals impacting capital structure and governance.

  • Proposals include authorizations for new share issuances, a reverse stock split, and potential adjournment to solicit additional votes.

  • Board recommends voting in favor of all proposals to support financing, acquisitions, and compliance with NYSE American rules.

  • Forward-looking statements highlight risks if proposals are not approved, including financing challenges and potential dilution.

Voting matters and shareholder proposals

  • Proposal 1: Approve issuance of shares underlying Series C Preferred Stock, potentially exceeding 19.99% of outstanding shares.

  • Proposal 2: Approve issuance of shares underlying Series D Preferred Stock for FLYTE and Ponderosa Air acquisitions.

  • Proposal 3: Approve issuance of shares underlying Series J Preferred Stock, converting royalty rights held by insiders.

  • Proposal 4: Approve additional shares due to reduced conversion price of Series B Preferred Stock.

  • Proposal 5: Approve a reverse stock split at a ratio between 1-for-2 and 1-for-100, at Board discretion.

  • Proposal 6: Approve adjournment or postponement of the meeting to solicit more votes if needed.

Board of directors and corporate governance

  • Board unanimously recommends voting “FOR” all proposals.

  • Independent directors approved insider-related transactions, with interested parties abstaining.

  • Board retains discretion on timing and ratio of reverse stock split.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more